Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00829673
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Zaleplon 10mg Capsules Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00829998
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00829712
- Locations
- 🇺🇸
Gateway Medical Research, Inc., Saint Charles, Missouri, United States
Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 30
- Registration Number
- NCT00830349
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Pravastatin Sodium 80 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Pravachol® 80 mg tablets
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00830258
- Locations
- 🇨🇦
Pharma Medica Research Inc., Toronto, Ontario, Canada
A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 80
- Registration Number
- NCT00830336
- Locations
- 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 80
- Registration Number
- NCT00830206
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Zaleplon 10 mg Capsules Under Non-Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 42
- Registration Number
- NCT00829868
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 40
- Registration Number
- NCT00829530
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Medroxyprogesterone Acetate Injection 150 mg/1 mL in Postmenopausal Women
- First Posted Date
- 2009-01-27
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 124
- Registration Number
- NCT00830414
- Locations
- 🇩🇪
AAI Deutschland GmbH & Co. KG, Neu-Ulm, Germany